- Lobbying
- teva AND pharmaceuticals AND usa
Lobbying Arrangements Results for 'Teva Pharmaceuticals Usa'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues |
TEVA PHARMACEUTICALS USA
|
RUBICON ADVISORS, LLC | |||
Details NOT APPLICABLE |
TEVA PHARMACEUTICALS USA, INC.
|
GOODWIN PROCTER LLP | |||
Details Communications issues impacting the generic and brand pharmaceutical industries |
Teva Pharmaceuticals USA, Inc.
|
Nahigian Strategies, LLC | |||
Details Issues related to health care reform and biogenerics legislation. Budget and appropriations issues. Import safety legislation. |
Teva Pharmaceuticals USA
|
Pier Strategies LLC | |||
Details H.R. 1427 S. 726 |
Teva Pharmaceuticals USA
Pharmaceutical company |
Cuneo Gilbert & LaDuca | |||
Details Section 505(b)(2) new drug applications and exclusivity period. |
TEVA PHARMACEUTICALS USA, INC.
|
Mr. Gary Buehler | |||
Details S. 214, the Preserve Access to Affordable Generics Act |
TEVA Pharmaceuticals USA Inc.
|
Kevin McGuiness PLLC | |||
Details Biogenerics S. 369, Patent settlement |
TEVA Pharmaceuticals USA
|
WINSTON & STRAWN LLP | |||
Details House and Senate legislation on biologic medicines. |
Teva Pharmaceuticals USA
|
KIRKLAND & ELLIS LLP | |||
Details Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies |
Teva Pharmaceuticals USA, Inc.
|
Polsinelli PC | |||
Details Trade agreements, including the Trans-Pacific Partnership (TPP); the Transatlantic Trade and Investment Partnership (TTIP); Trade Promotion Authority (TPA); intellectual property and access to medi... |
Teva Pharmaceuticals USA, Inc.
Pharmaceutical company |
MFJ INTERNATIONAL | |||
Details healthcare reform; drug prices healthcare reform; drug prices; issues related to opioids |
Teva Pharmaceuticals USA, Inc.
|
Gephardt Group Government Affairs | |||
Details Monitored legislation concerning promotion of generic drug use and medicaid Drug Shortages, FDA regulations Legislation affecting settlements between generic and all brand companies ... |
Teva Pharmaceuticals USA
|
Integrated Solutions Group | |||
Details Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369). |
TEVA PHARMACEUTICALS USA., INC.
|
WILLKIE FARR & GALLAGHER LLP | |||
Details Global supply chain issues; National Defense Authorization Act; Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133). |
Teva Pharmaceuticals USA, Inc.
|
Holland & Knight, LLP | |||
Details Issues related to affordability and pricing of pharmaceuticals including S.771 Improving Access to Affordable Prescription Drugs Act. Issues related to opioids Medicaid rebate CPI drug pricing is... |
Teva Pharmaceuticals USA
|
Loper Consulting LLC | |||
Details Proposals related to affordability and pricing of pharmaceuticals including issues related to H. R. 2212 and S. 974, CREATES Act of 2017; H. R. 2051 - FAST Generics Act. Proposals related to afford... |
TEVA Pharmaceuticals USA, Inc.
|
Kountoupes Denham Carr & Reid, LLC | |||
Details Use of Section viii statements in pharmaceutical labeling. FDAs approval of over-the-counter naloxone nasal spray. Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval pr... |
TEVA PHARMACEUTICALS USA, INC.
|
in-house lobbying | |||
Details Issues relating to the US-Israel Trade USTR Special 301 Report |
Teva Pharmaceuticals, USA
|
ARTEMIS STRATEGIES | |||
Details H.R. 2853 BLOCKING Act of 2021 (All sections of full text). S. 2910, Expanding Access to Low-Cost Generics Act of 2021 (All sections of full text). Discussions regarding S. 3799, PREVENT Pandemic... |
Teva Pharmaceuticals USA, Inc.
|
The Smith-Free Group, LLC | |||
Details Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues relate... |
Teva Pharmaceuticals USA
|
CAPITOL HILL CONSULTING GROUP | |||
Details Access to Life-Saving Medicine Act (H.R. 1038 & S. 623), Affordable Biologics for Consumers Act (S. 1505), Biologics Price Competition and Innovation Act of 2007 (S. 1695), Consumer Food Safety Act... |
Teva Pharmaceuticals USA
|
James P. Keese | |||
Details S. 515 - A bill to amend title 35, United States Code, to provide for patent reform. S. 610 - A bill to amend title 35, United States Code, to provide for patent reform. H.R. 1260 - To amend titl... |
Teva Pharmaceuticals USA, Inc.
|
TIMMONS AND COMPANY, INC. | |||
Details Issues related to drug patents. |
Teva Pharmaceuticals USA, Inc.
Drug manufacturer |
COLAS & ASSOCIATES, LLC |